Editorial Board

84 Editors in 15 Countries/Regions

China (41)
Italy (19)
United States (5)
Germany (4)
Singapore (3)
Greece (2)
South Korea (2)
Finland (1)
France (1)
Japan (1)
Spain (1)
Switzerland (1)
Taiwan (1)
Turkey (1)
United Kingdom (1)

Editor-in-Chief

Guangwen Cao

Guangwen Cao ORCID

gcao@smmu.edu.cn
Chairman, Professor, and PhD Supervisor at Department of Epidemiology, Second Military Medical University, Shanghai, China.
Research Interests:  hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, predicative biomarker, prognostic biomarkers

Executive Chief Editor

Giuliano Ramadori

Giuliano Ramadori ORCID

Professor of Medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
Research Interests:  gene expression, liver cells (hepatocytes, kupffer cells, endothelial cells, stellate cells), pathogenesis, inflammation, cancer development, animal models of liver cancer diagnostic procedures and therapy, COVID-19 diagnostic and treatment, mechanisms of acute-phaseresponse, gastrointestinal cancer diagnostic and endoscopic therapy, systemic cancer therapy, tumor microenviroment analysis, liver diseases diagnostic, therapy, iron metabolism, radiation biology

Honorary Editors-in-Chief

Masao Omata

Masao Omata ORCID

Department of Gastroenterology, University of Tokyo, Tokyo, Japan.
Research Interests:  hepatology, gastroenterology, oncology
Shukui Qin

Shukui Qin

Clinical Oncology Department, Nanjing Jinling Hospital, Nanjing, Jiangsu, China.
Research Interests:  gastrointestinal cancers, treatment, liver cancer, primary liver cancer

Senior Advisory Editor

Jia Fan

Jia Fan

Department of Liver Surgery, Fudan University, Shanghai, China.
Research Interests:  hepatocellular carcinoma, clinical diagnosis, treatment and basic research of liver cancer
Gaojun Teng

Gaojun Teng

Professor of Radiology, Academician of the Chinese Academy of Sciences (China), President of Chinese College of Interventionalists, Nanjing, China.
Research Interests:  portal hypertension, interventional oncology, nonvascular, musculoskeletal interventions, molecular and functional imagine

Associate Chief Editors

Antonio Bertoletti

Antonio Bertoletti ORCID

Division Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore City, Singapore.
Research Interests:  immunopathogenesis, hepatitis C virus infection, SARS-CoV1/2 infections, new immunological based therapies (T cell receptor-redirected T cells), treatment of hepatitis C virus, SARS-CoV-2, hepatocellular carcinoma
Huiguo Ding

Huiguo Ding ORCID

Department of Gastroenterology and Hepatology, Beijing You An Hospital affiliated to Capital Medical University, Beijing, China.
Research Interests:  clinical diagnosis, treatment and research of liver cirrhosis, portal hypertension and its complications, early liver cancer diagnosis and screening, ascites, gastrointestinal bleeding, malnutrition, hepatic encephalopathy, pancreatic biliary disease, endoscopic minimally invasive diagnosis and treatment
Guido Gerken

Guido Gerken

Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.
Research Interests:  internal medicine, gastroenterology, hepatology, clinical virology, clinical immunology, endoscopy, liver transplantation, autoimmunity, infectiology, visceral medicine, acute and terminal liver failure, molecular pathomechanisms of liver failure, fibrosis progression of chronic liver diseases, evaluation of mini-laparoscopy for the diagnosis of chronic liver diseases, crohn’s disease, ulcerative colitis, autoimmune hepatitis, viral hepatitis and HIV coinfection, hepatocellular carcinoma, establishment of biomarkers in gastroenterology
Nan Li

Nan Li ORCID

Department of Hepatic Surgery VI, AnTing District of the Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Research Interests:  hepatocellular carcinoma, HBV-DNA, metastasis, transformation, liver transplantation
Lianxin Liu

Lianxin Liu

Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Clinical Research Center for Hepatobiliary Diseases, Hefei, Anhui, China.
Research Interests:  hepatocellular carcinoma, cholangiocarcinoma, surgery, immunotherapy, liver cancer
Amedeo Lonardo

Amedeo Lonardo ORCID

Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.
Research Interests:  metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences in non-alcoholic fatty liver disease, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus infection, diabetes in cirrhosis
Chunfeng Qu

Chunfeng Qu ORCID

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Research Interests:  hepatocellular carcinoma, HBsAg, hepatitis B virus, prevention
Feng Shen

Feng Shen ORCID

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Research Interests:  intrahepatic cholangiocarcinoma, treatment of hepatobiliary and pancreatic diseases
Dar-In Tai

Dar-In Tai ORCID

Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Research Interests:  hepatitis B virus, genetic polymorphism, hepatocellular carcinoma family, elastography, liver ultrasound
Claudio Tiribelli

Claudio Tiribelli ORCID

Fondazione Italiana Fegato – Italian Liver Foundation NPO, AREA Science Park, Trieste, Italy.
Research Interests:  bilirubin, neonatal jaundice, metabolic liver diseases, hepatocellular carcinoma, stem cells in hepatocellular carcinoma, crigler-najjar syndrome, translational medicine
Georgios Tsoulfas

Georgios Tsoulfas ORCID

Surgery, Aristoteleion University of Thessaloniki, Thessaloniki, Greece.
Research Interests:  hepatobiliary surgery, primary and secondary hepatic malignancies, ischemia/reperfusion injury, solid organ transplantation, medical/surgical education, 3D printing
Kaichun Wu

Kaichun Wu ORCID

Emergency Room of Digestive Diseases, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xi'an, Shaanxi, China.
Research Interests:  gastrointestinal cancers, treatment, liver cancer, gut
Hongping Xia

Hongping Xia ORCID

School of Basic Medical Sciences & State Key Laboratory of Reproductive Medicine & Key Laboratory of Antibody Technique of National Health Commission & Jiangsu Antibody Drug Engineering Research Center, Nanjing Medical University, Nanjing, Jiangsu, China.
Research Interests:  viral and non-viral hepatocellular carcinoma, target therapy, molecular pathology, noncoding RNAs, immunotherapy
Limin Xia

Limin Xia ORCID

Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Research Interests:  hepatocellular carcinoma, immunosuppressive microenvironment, myeloid cell, tumor microenvironment, CD8+T cell
Yongbing Xiang

Yongbing Xiang ORCID

Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests:  cancer statistics, cancer epidemiology, survival analysis, meta-analysis, cancer prevention
Fu Yang

Fu Yang ORCID

Department of Medical Genetics, Second Military Medical University, Shanghai, China.
Research Interests:  hepatocellular carcinoma, epigenetics, RNA post-transcriptional modification, tumor energy metabolism, tumor microenvironment, tumor immunity
Xinrong Yang

Xinrong Yang ORCID

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Research Interests:  diagnosis and surgical treatment of liver tumours, liver transplantation, clinical and translational research of hepatocellular carcinoma (HCC), liver cancer stem cell, circulating tumor cells

Editorial Board Members

Amedeo Amedei

Amedeo Amedei

University of Florence, Florence, Italy.
Research Interests:  Immunity, microbiome, cancer, neurodegenerative disorders, autoimmunity
Francesco Ardito

Francesco Ardito ORCID

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
Research Interests:  minimally invasive liver surgery, liver resection for malignant and benign hepatobiliary disease, hepatocellular carcinoma, cholangiocarcinoma, liver metastases
Eliza Wright Beal

Eliza Wright Beal ORCID

Departments of Surgery and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Research Interests:  surveillance for hepatocellular carcinoma, treatment of hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, cirrhosis, minimally invasive hepatectomy, systemic cancer therapy, intrahepatic cholangiocarcinoma
Stefano Bellentani

Stefano Bellentani ORCID

Presidente, Lifestyle Medical Clinic SAGL, Via Della Pace 3, Locarno, Switzerland.
Research Interests:  metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus
Andrea Belli

Andrea Belli ORCID

Department of Abdominal Oncology, HPB Surgical Oncology, National Cancer Institute - G. Pascale - IRCCS, Naples, Italy.
Research Interests:  liver resection, minimally invasive surgery, robotic surgery, hepatocellular carcinoma, cholangiocarcinoma
Stephen Lam Chan

Stephen Lam Chan

State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Research Interests:  Clinical and translational researches on hepato-pancreatobiliary cancers and neuroendocrine tumours
Lei Chen

Lei Chen

The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Research Interests:  heterogeneity of tumor microenvironment in liver cancer, the potential mechanism of driver gene associated tumor microenvironment remodeling, early diagnosis and precaution of liver cancer
Shuqun Cheng

Shuqun Cheng

Shanghai Oriental Hepatobiliary Surgery Hospital,Shanghai, China.
Research Interests:  hepatocellular carcinoma, liver transplantation, surgical treatment, prognosis, recurrence
Kenneth Siu Ho Chok

Kenneth Siu Ho Chok ORCID

Department of Surgery, University of Hong Kong, Hongkong, China.
Research Interests:  hepatocellular carcinoma, liver transplantation, intrahepatic cholangiocarcinoma
Evangelos Cholongitas

Evangelos Cholongitas ORCID

First Department of Internal Medicine, "Laiko" General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.
Research Interests:  cirrhosis, liver transplantation, NAFLD, hepatocellular carcinoma
Paolo De Simone

Paolo De Simone ORCID

Liver transplantation program, University of Pisa Medical School Hospital, Pisa, Italy.
Research Interests:  liver transplant, liver surgery, liver malignancy, hepatocellular carcinoma, donor surgery
Renumathy Dhanasekaran

Renumathy Dhanasekaran ORCID

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Research Interests:  liver cancer, HCC, tumor progression, cancer immunology, macrophages
Marcello Di Martino

Marcello Di Martino ORCID

Department of Hepatobiliary and Liver Transplant Surgery, A.O.R.N. Cardarelli, Naples, Italy.
Research Interests:  hepatocellular carcinoma, liver metastasis, liver cirrhosis, liver imaging, liver resection
Jin Ding

Jin Ding

Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai 200433, China.
Research Interests:  liver cancer stem cell, targeted drug resistance, differentiation therapy
Matteo Donadon

Matteo Donadon ORCID

Division of Surgical Oncology, Department of Surgery, University Maggiore Hospital della Carità, Novara, Italy.
Research Interests:  surgical oncology of hepatobiliary and pancreatic diseases, surgical techniques, mininvasive approaches, surgical outcomes measures, hepatocellular carcinoma, cholangiocarcinoma, systemic treatments, translational research
Jean-François Dufour

Jean-François Dufour

Centre for Digestive Diseases, Lausanne, Switzerland.
Research Interests:  MASLD, MASH, hepatocellular carcinoma
Jiangao Fan

Jiangao Fan

Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests:  fatty liver, non-alcoholic liver disease, metabolic syndrome, obesity, type 2 diabetes, hepatocellular carcinoma
Lynn G. Feun

Lynn G. Feun ORCID

Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA.
Research Interests:  hepatocellular carcinoma, biomarkers, clinical trials, immunotherapy
Richard S. Finn

Richard S. Finn

Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Research Interests:  molecular therapies for hepatocellular carcinoma, systemic therapy, therapeutic strategies
Alessandro Granito

Alessandro Granito ORCID

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Research Interests:  autoimmune liver diseases, autoimmune hepatitis, autoimmune cirrhosis, hepatocellular carcinoma, cancer immunotherapy, cancer immunotherapy related adverse events
Guohong Han

Guohong Han

Department of Oncology, Xi'an International Medical Center Hospital, Xi'an, Shaanxi , China.
Research Interests:  portal hypertension, hepatobiliary and pancreatic tumors, interventional oncology, immunotherapy
Ho Seong Han

Ho Seong Han ORCID

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Research Interests:  hepatobiliary-pancreatic surgery, hepatocellular carcinoma, pancreas cancer, biliary tract cancer
Michael A. Heneghan

Michael A. Heneghan

Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK.
Research Interests:  autoimmune hepatitis, liver transplant, acute liver failure, primary biliary cholangitis
Jinlin Hou

Jinlin Hou

Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Research Interests:  clinical management of viral hepatitis, molecular virology, immunology of hepatitis B virus (HBV), severe acute respiratory syndrome (SARS) infection
Roberto Iezzi

Roberto Iezzi

Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Research Interests:  interventional oncology, hepatobiliary locoregional treatments, hepatocellular carcinoma, cholangiocarcinoma, colorectal metastases, ablation, chemoembolization, radioembolization, technical innovation
David K. Imagawa

David K. Imagawa

Department of Surgery, Irvine Medical Center, University of California, Orange, CA, USA.
Research Interests:  bile duct cancer, liver cancer, treatment of bile duct injuries, chemoembolization, hemostatic agents
Jeong Won Jang

Jeong Won Jang

Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Research Interests:  hepatocellular carcinoma, hepatitis B, HBV carcinogenesis, biomarkers, prevention and management
Deke Jiang

Deke Jiang ORCID

State Key Laboratory of Organ Failure Research, Guangdong Key Laboratory of Viral Hepatitis Research, Institutes of Liver Diseases Research of Guangdong Province, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Research Interests:  genetic epidemiology, epigenetics, pharmacogenomics, molecular mechanism, chronic hepatitis B, hepatocellular carcinoma
Thomas Kietzmann

Thomas Kietzmann ORCID

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Biocenter Oulu, Oulu, Finland.
Research Interests:  hypoxia, reactive oxygen species (ROS) Cancer, liver metabolism and zonation, cell signaling and transcriptional regulation, hemostasis and fibrinolysis, obesity and diabetes, insulin signaling, protein structure and stability
Terence Kin Wah Lee

Terence Kin Wah Lee

Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
Research Interests:  cancer stem cells, gut microbiota, therapeutic resistance, cancer immunology, hepatocellular carcinoma
Tingbo Liang

Tingbo Liang

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Research Interests:  hepatobiliary and pancreatic surgery, organ transplantation, tumor immunity, hepatocellular carcinoma
Xiaohong Liang

Xiaohong Liang

Shandong University, Jinan, China.
Research Interests:  liver immmune regulation
Yinying Lu

Yinying Lu

Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Research Interests:  hepatocellular carcinoma, immunotherapy, liver tumor
Chunhong Ma

Chunhong Ma ORCID

School of Basic Medical Science, Shandong University, Jinan, Shandong, China.
Research Interests:  immune regulation, liver diseases, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, immunology
Jose J. G. Marin

Jose J. G. Marin ORCID

Laboratory of Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Investigation of Salamanca (IBSAL), Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; National Center for the Study of Liver and Digestive Diseases (CIBEREHD), Carlos III National Institute of Health, Madrid, Spain.
Research Interests:  liver cancer, chemoresistance characterization and sensitization, drug targeting, gene therapy strategies
Gabriele Missale

Gabriele Missale ORCID

Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Parma, Italy.
Research Interests:  hepatocellular carcinoma, tumor immune microenvironment, hepatitis B virus, hepatitis C virus, immuneresponse, T cell, NK cell
Necati Örmeci

Necati Örmeci

Department of Gastroenterology, Istanbul Health and Technology University, Istanbul, Türkiye.
Research Interests:  hepatitis B virus, hepatitis C virus, hepatitis D virus, hepatocellular carcinoma, hydatid cyst, portal hypertension
Valérie Paradis

Valérie Paradis ORCID

Pathology Department, Hôpital Beaujon, AP-HP, Clichy, France.
Research Interests:  liver tumors, tumor heterogeneity, molecular imaging, preneoplastic liver lesions
Tao Peng

Tao Peng

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Research Interests:  hepatocellular carcinoma, biomarkers, hepatitis B virus, liver surgery
Lunxiu Qin

Lunxiu Qin

Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Research Interests:  liver cancer, hepatobiliary surgery, tumor microenvironment, cancer metastasis, molecular targeted therapy, immunotherapy, cancer biology, surgical techniques, early cancer diagnosis, translational medicine
Wenxin Qin

Wenxin Qin

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai, China.
Research Interests:  molecular mechanism of hepatocarcinogenesis, novel strategies for diagnosis and treatment of hepatocellular carcinoma
Matteo Ravaioli

Matteo Ravaioli ORCID

General Surgery and Transplant Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Research Interests:  liver and kidney transplantation, liver resection, hepato-pancreato-biliary surgery, ex-vivo perfusion and regenerative medicine, liver oncology
Lorenza Rimassa

Lorenza Rimassa ORCID

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Research Interests:  hepatocellular carcinoma, biliary tract cancer, cholangiocarcinoma, liver cancer, new drugs, targeted agents, immunotherapy, biomarkers
Andrea Ruzzenente

Andrea Ruzzenente ORCID

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, GB Rossi University Hospital, University of Verona, Verona, Italy.
Research Interests:  minimally invasive liver surgery, robotic liver surgery, cholangiocarcinoma
Fuat H. Saner

Fuat H. Saner

Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Research Interests:  liver cancer, acute and chronic liver failure, liver transplantation
Robert Schierwagen

Robert Schierwagen

Universitätsklinikum Münster, Munster, Germany.
Research Interests:  advanced chronic liver diseases and the transition to malignancy, gut-liver axis, hepatocellular carcinoma, circulating biomarkers
Vishalkumar G. Shelat

Vishalkumar G. Shelat ORCID

Tan Tock Seng Hospital, Singapore City, Singapore.
Research Interests:  hepato-pancreatico-biliary surgery, liver resection, hepatocellular carcinoma, robotic hepatobiliary, pancreatic surgery
Ni Tang

Ni Tang

Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Research Interests:  hepatocellular carcinoma, O-GlcNAcylation, cancer metabolism, hepatitis B Virus, tumor microenvironment
Pierluigi Toniutto

Pierluigi Toniutto ORCID

Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.
Research Interests:  liver cirrhosis, hepatocellular carcinoma, portal hypertension, viral hepatitis, liver transplantation
Roberto Ivan Troisi

Roberto Ivan Troisi ORCID

Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Research Interests:  hepatocellular carcinoma, laparoscopic surgery, robotic surgery, robotic donor hepatectomy, liver transplantation, living donor liver transplant
Hong Tu

Hong Tu ORCID

Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Research Interests:  hepatitis B virus-related hepatocellular carcinoma carcinogenesis, hepatocellular carcinoma prediction, hepatocellular carcinoma prevention, tumor marker of hepatocellular carcinoma
Erica Villa

Erica Villa ORCID

Division of Gastroenterology, University of Modena and Reggio Emilia, Modena, Italy.
Research Interests:  hepatitis C virus, cirrhosis, direct-acting antiviral therapy, genotype, hepatitis B virus, platelets, portal hypertension, coagulation
Alessandro Vitale

Alessandro Vitale ORCID

Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Second General Surgical Unit, Padova Teaching Hospital, Padua, Italy.
Research Interests:  hepatocellular carcinoma, liver cancer, hepatobiliary surgery, liver transplantation, MASLD
Cun Wang

Cun Wang

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests:  exploring novel therapeutic strategies for liver cancer, functional genetic screening
Carmen Chak-Lui Wong

Carmen Chak-Lui Wong

State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
Research Interests:  tumor microenvironment, immunology, metabolism, immunotherapy, precision medicine, hepatocellular carcinoma
Rongqian Wu

Rongqian Wu ORCID

Research Institute of Advanced Surgical Technology and Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Research Interests:  hepatocellular carcinoma, fatty liver disease, liver transplantation, ischemia reperfusion injury
Bangde Xiang

Bangde Xiang

The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Research Interests:  surveillance, prognostic biomarkers, adjuvant therapy, recurrence after hepatectomy
Xiao Xu

Xiao Xu ORCID

Institute of Translational Medicine of Zhejiang University, Hangzhou Medical College, Hangzhou, China.
Research Interests:  transplant oncology, regenerative medicine
Dengfu Yao

Dengfu Yao ORCID

Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Research Interests:  early diagnosis and pathogenesis of hepatocellular carcinoma, hepatocarcinogenesis, biomarkers
Jianhua Yin

Jianhua Yin ORCID

Department of Epidemiology, Second Military Medical University, Shanghai, China.
Research Interests:  hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, biomarker
Hongmei Zeng

Hongmei Zeng

National Cancer Centre, Cancer Hospital of the Chinese Academy of Medical Sciences, Beijing, China.
Research Interests:  liver cancer epidemiology, cancer burden analysis, population prevention strategies, screening & early detection, cancer registry big data

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/